Dithranol is a hydroxyanthrone derivative and anthraquinone primarily utilized in dermatology as a topical treatment for psoriasis and other inflammatory skin disorders. By inhibiting excessive keratinocyte… Read more











Dithranol is a hydroxyanthrone derivative and anthraquinone primarily utilized in dermatology as a topical treatment for psoriasis and other inflammatory skin disorders. By inhibiting excessive keratinocyte proliferation and modulating local immune responses, it serves as an effective therapeutic agent. To support rigorous quality control and method validation in pharmaceutical analysis, laboratories rely on high-quality reference standards of the active pharmaceutical ingredient. This category encompasses the parent drug along with its related substances, including critical impurities like 1,8-dihydroxyanthraquinone (danthron) and various dimeric forms. Access to these specific compounds, including relevant stable isotope labelled standards, is essential for accurate impurity profiling and ensuring compliance with regulatory requirements during the development and stability testing of pharmaceutical preparations.